Tarcsay L - Search Results

1

Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis.

Odink K, Cerletti N, Brüggen J, Clerc RG, Tarcsay L, Zwadlo G, Gerhards G, Schlegel R, Sorg C. Odink K, et al. Among authors: tarcsay l. Nature. 1987 Nov 5-11;330(6143):80-2. doi: 10.1038/330080a0. Nature. 1987. PMID: 3313057

2

Restin: a novel intermediate filament-associated protein highly expressed in the Reed-Sternberg cells of Hodgkin's disease.

Bilbe G, Delabie J, Brüggen J, Richener H, Asselbergs FA, Cerletti N, Sorg C, Odink K, Tarcsay L, Wiesendanger W, et al. Bilbe G, et al. Among authors: tarcsay l. EMBO J. 1992 Jun;11(6):2103-13. doi: 10.1002/j.1460-2075.1992.tb05269.x. EMBO J. 1992. PMID: 1600942 Free PMC article.

3

The molecular nature of the cystic fibrosis antigen.

Brüggen J, Tarcsay L, Cerletti N, Odink K, Rutishauser M, Holländer G, Sorg C. Brüggen J, et al. Among authors: tarcsay l. Nature. 1988 Feb 18;331(6157):570. doi: 10.1038/331570a0. Nature. 1988. PMID: 3340209 No abstract available.

4

Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma.

Delabie J, Shipman R, Brüggen J, De Strooper B, van Leuven F, Tarcsay L, Cerletti N, Odink K, Diehl V, Bilbe G, et al. Delabie J, et al. Among authors: tarcsay l. Blood. 1992 Dec 1;80(11):2891-6. Blood. 1992. PMID: 1450414 Free article.

5

Generation and characterization of a monoclonal antibody (1C5) to human migration inhibitory factor (MIF).

Burmeister G, Tarcsay L, Sorg C. Burmeister G, et al. Among authors: tarcsay l. Immunobiology. 1986 Jul;171(4-5):461-74. doi: 10.1016/S0171-2985(86)80077-8. Immunobiology. 1986. PMID: 3527953

6

Maintenance of intestinal epithelium structural integrity and mucosal leukocytes during chemotherapy by oral administration of muramyl tripeptide phosphatidylethanolamine.

Killion JJ, Bucana CD, Radinsky R, Dong Z, O'Reilly T, Bilbe G, Tarcsay L, Fidler IJ. Killion JJ, et al. Among authors: tarcsay l. Cancer Biother Radiopharm. 1996 Dec;11(6):363-71. doi: 10.1089/cbr.1996.11.363. Cancer Biother Radiopharm. 1996. PMID: 10851497

7

Analysis of the antimetastatic effects of synthetic muramyl tripeptide (CGP 19835A) encapsulated in liposomes in combination with other immunomodulatory agents and chemotherapeutic drugs.

Bezault J, Walsh C, Tarcsay L, Frost H, Liebes L, Furmanski P. Bezault J, et al. Among authors: tarcsay l. In Vivo. 1993 Nov-Dec;7(6A):487-91. In Vivo. 1993. PMID: 8193265

8

Pharmacokinetics and immunomodulatory effects on monocytes during prolonged therapy with liposomal muramyltripeptide.

Landmann R, Obrist R, Denz H, Ludwig C, Frost H, Wesp M, Rordorf C, Towbin H, Gygax D, Tarcsay L, et al. Landmann R, et al. Among authors: tarcsay l. Biotherapy. 1993;7(1):1-12. doi: 10.1007/BF01878149. Biotherapy. 1993. PMID: 8068481 Clinical Trial.

9

Origin and fate of IgE-bearing lymphocytes. II. Modulation of IgE isotype expression on Peyer's patch cells by feeding with certain bacteria and bacterial cell wall components or by thymectomy.

Durkin HG, Chice SM, Gaetjens E, Bazin H, Tarcsay L, Dukor P. Durkin HG, et al. Among authors: tarcsay l. J Immunol. 1989 Sep 15;143(6):1777-83. J Immunol. 1989. PMID: 2789249

10

Control of IgE responses.

Durkin HG, Auci DL, Chice SM, Smith MC, Murali MR, Bazin H, Tarcsay L, Dukor P. Durkin HG, et al. Among authors: tarcsay l. Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 2):S52-72. doi: 10.1016/0090-1229(89)90113-x. Clin Immunol Immunopathol. 1989. PMID: 2783405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters